1. Home
  2. VIR vs LXU Comparison

VIR vs LXU Comparison

Compare VIR & LXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • LXU
  • Stock Information
  • Founded
  • VIR 2016
  • LXU 1968
  • Country
  • VIR United States
  • LXU United States
  • Employees
  • VIR N/A
  • LXU N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • LXU Major Chemicals
  • Sector
  • VIR Health Care
  • LXU Industrials
  • Exchange
  • VIR Nasdaq
  • LXU Nasdaq
  • Market Cap
  • VIR 706.4M
  • LXU 612.4M
  • IPO Year
  • VIR 2019
  • LXU 1969
  • Fundamental
  • Price
  • VIR $5.08
  • LXU $8.05
  • Analyst Decision
  • VIR Strong Buy
  • LXU Buy
  • Analyst Count
  • VIR 10
  • LXU 3
  • Target Price
  • VIR $26.80
  • LXU $10.08
  • AVG Volume (30 Days)
  • VIR 1.5M
  • LXU 360.1K
  • Earning Date
  • VIR 10-30-2025
  • LXU 10-28-2025
  • Dividend Yield
  • VIR N/A
  • LXU N/A
  • EPS Growth
  • VIR N/A
  • LXU N/A
  • EPS
  • VIR N/A
  • LXU N/A
  • Revenue
  • VIR $19,000,000.00
  • LXU $538,851,000.00
  • Revenue This Year
  • VIR N/A
  • LXU $13.07
  • Revenue Next Year
  • VIR $9.65
  • LXU N/A
  • P/E Ratio
  • VIR N/A
  • LXU N/A
  • Revenue Growth
  • VIR N/A
  • LXU 2.60
  • 52 Week Low
  • VIR $4.16
  • LXU $4.88
  • 52 Week High
  • VIR $14.45
  • LXU $9.68
  • Technical
  • Relative Strength Index (RSI)
  • VIR 51.83
  • LXU 49.56
  • Support Level
  • VIR $5.04
  • LXU $7.72
  • Resistance Level
  • VIR $5.39
  • LXU $8.20
  • Average True Range (ATR)
  • VIR 0.34
  • LXU 0.29
  • MACD
  • VIR 0.05
  • LXU -0.02
  • Stochastic Oscillator
  • VIR 49.20
  • LXU 40.00

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About LXU LSB Industries Inc.

LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.

Share on Social Networks: